BiotechTube
Home/Kling Biotherapeutics/Tim Wright
TW

Tim Wright

Chairman of the Board

Kling Biotherapeutics

Therapeutic Areas

OncologyInfectious Diseases

Kling Biotherapeutics Pipeline

DrugIndicationPhase
KBA1412Oncology (likely solid tumors)Phase 1

Leadership Team at Kling Biotherapeutics

SG
Stefano Gulla
Chief Scientific Officer (CSO)
View full Kling Biotherapeutics profile